SE464301B - Foerfarande foer framstaellning av enkainid - Google Patents

Foerfarande foer framstaellning av enkainid

Info

Publication number
SE464301B
SE464301B SE8700776A SE8700776A SE464301B SE 464301 B SE464301 B SE 464301B SE 8700776 A SE8700776 A SE 8700776A SE 8700776 A SE8700776 A SE 8700776A SE 464301 B SE464301 B SE 464301B
Authority
SE
Sweden
Prior art keywords
methyl
hydrochloride
iii
product
acetone
Prior art date
Application number
SE8700776A
Other languages
English (en)
Swedish (sv)
Other versions
SE8700776L (sv
SE8700776D0 (sv
Inventor
J L Dillon
R H Spector
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of SE8700776D0 publication Critical patent/SE8700776D0/xx
Publication of SE8700776L publication Critical patent/SE8700776L/xx
Publication of SE464301B publication Critical patent/SE464301B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02—Preparation by ring-closure or hydrogenation

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE8700776A 1986-02-25 1987-02-24 Foerfarande foer framstaellning av enkainid SE464301B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/833,295 US4675409A (en) 1986-02-25 1986-02-25 Process for the preparation of encainide

Publications (3)

Publication Number Publication Date
SE8700776D0 SE8700776D0 (sv) 1987-02-24
SE8700776L SE8700776L (sv) 1987-08-26
SE464301B true SE464301B (sv) 1991-04-08

Family

ID=25264016

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8700776A SE464301B (sv) 1986-02-25 1987-02-24 Foerfarande foer framstaellning av enkainid

Country Status (23)

Country Link
US (1) US4675409A (de)
JP (1) JPS62240659A (de)
KR (1) KR900001203B1 (de)
AT (1) AT394716B (de)
AU (1) AU597939B2 (de)
BE (1) BE1000112A5 (de)
CA (1) CA1291483C (de)
CH (1) CH671223A5 (de)
DE (1) DE3705664A1 (de)
DK (1) DK94487A (de)
ES (2) ES2002637A6 (de)
FI (1) FI85853C (de)
FR (1) FR2595353B1 (de)
GB (1) GB2187189B (de)
GR (1) GR870281B (de)
HU (1) HU196960B (de)
IL (1) IL81657A0 (de)
IT (1) IT1203501B (de)
LU (1) LU86785A1 (de)
NL (1) NL8700452A (de)
PT (1) PT84348B (de)
SE (1) SE464301B (de)
ZA (1) ZA871334B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800226A (en) * 1986-02-25 1989-01-24 Bristol-Myers Company Process intermediate for the preparation of encainide
EP1994001A2 (de) * 2005-11-17 2008-11-26 Novartis AG Benzeneszkfibat-salze und ihre verwendung als zwischenprodukte zur synthese von 2-[2-(1-alkyl-2-piperidyl)ethyl]-cinnamaniliden

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines
CA961038A (en) * 1971-03-03 1975-01-14 Bristol-Myers Canada Limited Substituted piperidines
US4000143A (en) * 1971-03-03 1976-12-28 Mead Johnson & Company Substituted piperidines
US4064254A (en) * 1971-03-03 1977-12-20 Mead Johnson & Company Substituted piperidines therapeutic process and compositions
US4394507A (en) * 1981-12-14 1983-07-19 Mead Johnson & Company Process for production of encainide

Also Published As

Publication number Publication date
PT84348A (en) 1987-03-01
GB2187189B (en) 1990-01-10
NL8700452A (nl) 1987-09-16
FI85853C (fi) 1992-06-10
ATA41287A (de) 1991-11-15
FI85853B (fi) 1992-02-28
SE8700776L (sv) 1987-08-26
CH671223A5 (de) 1989-08-15
HUT43563A (en) 1987-11-30
AU597939B2 (en) 1990-06-14
AU6924687A (en) 1987-08-27
PT84348B (pt) 1989-09-14
CA1291483C (en) 1991-10-29
IL81657A0 (en) 1987-09-16
JPS62240659A (ja) 1987-10-21
ZA871334B (en) 1987-10-28
KR870007887A (ko) 1987-09-22
US4675409A (en) 1987-06-23
FR2595353A1 (fr) 1987-09-11
ES2002637A6 (es) 1988-09-01
ES2007062A6 (es) 1989-06-01
GB2187189A (en) 1987-09-03
DK94487D0 (da) 1987-02-24
FI870767L (fi) 1987-08-26
FR2595353B1 (fr) 1990-11-30
HU196960B (en) 1989-02-28
SE8700776D0 (sv) 1987-02-24
IT8719475A0 (it) 1987-02-24
AT394716B (de) 1992-06-10
DE3705664C2 (de) 1989-09-28
IT1203501B (it) 1989-02-15
DE3705664A1 (de) 1987-08-27
KR900001203B1 (ko) 1990-02-28
BE1000112A5 (fr) 1988-03-29
GB8703882D0 (en) 1987-03-25
LU86785A1 (fr) 1987-09-15
FI870767A0 (fi) 1987-02-23
DK94487A (da) 1987-08-26
GR870281B (en) 1987-06-30

Similar Documents

Publication Publication Date Title
SU967275A3 (ru) Способ получени 4-фенилпиперидинов или их солей
US4595765A (en) Process for preparing 5,6-dihydroxyindole
FI89906C (fi) Foerfarande foer framstaellning av aminocyanacetamid
CN117447387A (zh) 一种利特昔替尼关键中间体的制备方法
US5371237A (en) Process for the production of 4-hydroxy-2-oxopyrrolidin-1-yl-acetamide
Bowman et al. Regioselective synthesis of N-alkyl pyridones
US6225473B1 (en) Method for producing (−)cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-piperidine
US5744648A (en) Process for the manufacture of 1, 3-cyclohexanedione
Neumeyer et al. Chemistry of aporphines. IV. Synthesis of aporphines via Reissert alkylation, photochemical cyclization, and the Pschorr cyclization route
AU597939B2 (en) Process for the preparation of encainide
US4800226A (en) Process intermediate for the preparation of encainide
EP1464638A1 (de) Verfahren zur Herstellung von Erythro 3-Amino-2-Hydroxybuttersäurederivaten
US3952010A (en) Catalytic dehydrogenation process for the preparation of 3,5-disubstituted pyrazoles
US3017427A (en) 4-amino-2-sulfamylbenzoic acid esters
US3391143A (en) 9-piperidyl and 9-piperidylidene derivatives of acridan
EP0058071A2 (de) Verfahren und Zwischenverbindungen zur Herstellung von Pirbuterol
Yasuda et al. Base-catalyzed reactions of. alpha.-cyano-. beta.-furylacrylic esters
JP2820429B2 (ja) 3―(3,4,5,6―テトラヒドロフタルイミド)―ベンズアルデヒドの製法
EP0251547A2 (de) Chiral-Synthese von (+)-Trans-1a-2,3,4A,5,6-hexahydro-9-hydroxy-4-propyl-4H-naphth-(1,2-B)-1,4-oxazin
CN108484455B (zh) 一种合成手性光学纯对甲苯亚磺酰胺的方法
US4376860A (en) Pyridyl ketone
US4496762A (en) Process for the preparation of N-(2-(cyclo-hexen-1-yl)ethyl)-4-methoxybenzeneacetamide
SU487484A3 (ru) Способ получени производных 1-фенокси3-аминопропан-2-ола
Depreux et al. An improved synthesis of α, β methylenic cyclic ketones
HUT73809A (en) 4-amino-3-hydroxy-phthalimidine and process for producing it

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8700776-1

Effective date: 19940910

Format of ref document f/p: F